Get the Stockscreener App
13.90
1.09%
0.15
After Hours:
13.90
Carlsmed Inc stock is traded at $13.90, with a volume of 74,503.
It is up +1.09% in the last 24 hours and down -4.14% over the past month.
Carlsmed Inc is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. It is focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of AI-enabled software solutions, and interbody implants that it custom design for each patient's unique pathology and vertebral bone topography, and single-use surgical instruments. The Company designs, manufactures, and markets aprevo, a comprehensive technology platform for spine fusion surgery procedures.
See More
Previous Close:
$13.75
Open:
$13.77
24h Volume:
74,503
Relative Volume:
1.08
Market Cap:
$368.58M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+15.16%
1M Performance:
-4.14%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$13.52
$14.20
1-Week Range:
$12.15
$14.60
52-Week Range:
$11.81
$15.10
Carlsmed Inc Stock (CARL) Company Profile
Name
Carlsmed Inc
Sector
Industry
Phone
-
Address
-
Compare CARL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
13.90 | 364.60M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
293.59 | 46.82B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
73.23 | 13.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.99 | 12.56B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
87.98 | 7.72B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.17 | 6.47B | 906.14M | -52.62M | 89.62M | -0.3621 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Initiated | BTIG Research | Buy |
| Aug-18-25 | Initiated | BofA Securities | Buy |
| Aug-18-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Initiated | Piper Sandler | Overweight |
| Aug-18-25 | Initiated | Truist | Buy |
Carlsmed Inc Stock (CARL) Latest News
Carlsmed CARL 2025Q2 Earnings Preview Upside Potential on AI-Driven Spine Solutions - AInvest
Truist Securities initiates coverage on Carlsmed stock with Buy rating By Investing.com - Investing.com South Africa
Carlsmed initiated with Buy at Truist on business potential - MSN
Why Is Carlsmed Stock Gaining Monday?Carlsmed (NASDAQ:CARL) - Benzinga
AI medtech firm Carlsmed prices $100.5M IPO - MSN
Truist Initiates Buy on Carlsmed with Focus on Business Growth Potential - AInvest
Carlsmed initiated with Buy at Truist on business potential (CARL) - Seeking Alpha
BofA Securities Initiates Coverage on Carlsmed With Buy Rating, $16 Price Target - MarketScreener
This Synaptics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Goldman Sachs Initiates Coverage on Carlsmed With Buy Rating, $19 Price Target - MarketScreener
Carlsmed initiated with a Buy at BTIG - TipRanks
Truist Securities initiates coverage on Carlsmed stock with Buy rating - Investing.com
Truist Initiates Carlsmed at Buy With $18 Price Target - MarketScreener
Piper Sandler initiates coverage on Carlsmed with an Overweight rating, PT of $18. - AInvest
Buy Rating for Carlsmed: Innovative Aprevo Technology and Strong Growth Projections Justify Premium Valuation - TipRanks
Carlsmed stock initiated with Buy rating at BTIG on customized implant tech - Investing.com
Carlsmed stock initiated with Buy rating at BTIG on customized implant tech By Investing.com - Investing.com South Africa
Carlsmed initiated with an Overweight at Piper Sandler - TipRanks
Piper Sandler initiates Carlsmed stock with Overweight rating on custom implant potential - Investing.com India
Goldman Sachs initiates coverage on Carlsmed stock with Buy rating - Investing.com
Goldman Sachs initiates coverage on Carlsmed stock with Buy rating By Investing.com - Investing.com Nigeria
Carlsmed initiated with a Buy at Goldman Sachs - MSN
Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish - Stocktwits
AI medtech firm Carlsmed to sell 6.7M shares in IPO - MSN
Carlsmed, Inc. shares fall 2.01% after-hours as it prepares to report Q2 2025 financial results. - AInvest
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - The Manila Times
Carlsmed to report Q2 2025 financial results on Aug 28, 2025. - AInvest
Big Boost for Personalized Cervical Fusion: Add-On Code - Orthopedics This Week
Heartflow raises $317M, pops 66% at market open - BioWorld MedTech
Carlsmed’s $100.5M IPO fuels 3D printed spinal implants growth - 3D Printing Industry
Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures - TipRanks
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Ortho Spine News
Carlsmed's Aprevo Implants Receive CMS NTAP Approval For Cervical Fusion Procedures Under FY2026 IPPS Final Rule - 富途牛牛
Carlsmed's Aprevo Personalized Interbody Implants Receive CMS NTAP for Cervical Fusion Procedures - AInvest
US Life Sciences IPOs Revive with Medtech Companies Leading the Way - AInvest
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - Bloomberg.com
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery - MarketScreener
Carlsmed announces completion of first aprevo cervical procedure - TipRanks
Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery - Ortho Spine News
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery. - AInvest
Carlsmed’s Nasdaq Debut Gets $100.5M - San Diego Business Journal
Carlsmed Launches $100.5 Million Initial Public Offering - Global Legal Chronicle
Carlsbad-based medical technology company begins trading on Nasdaq - MSN
Latham & Watkins Advises on Carlsmed, Inc.’s US$100.5 Million Initial Public Offering - Latham & Watkins LLP
Carlsmed Insider Bought Shares Worth $899,985, According to a Recent SEC Filing - MarketScreener
B Capital Global Growth III buys $20 million in Carlmed (CARL) - Investing.com India
Carlsmed director Philip Young buys $900k in shares By Investing.com - Investing.com Canada
Carlsmed (CARL) director Sidow buys $199,995 in shares By Investing.com - Investing.com India
Carlsmed (CARL) director Sidow buys $199,995 in shares - Investing.com Australia
Carlsmed Inc Stock (CARL) Financials Data
There is no financial data for Carlsmed Inc (CARL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.86%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):